Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2026-01-06 @ 3:41 PM
Study NCT ID:
NCT00654758
Status:
COMPLETED
Last Update Posted:
2017-11-21
First Post:
2008-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-04
First Submit QC Date:
None
Study First Post Date:
2008-04-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-17
Last Update Post Date:
2017-11-21
Last Update Post Date Type:
ACTUAL